Reply #7: The top pulmonary hypertension doctors in the US [View All]

[teryang]

...were invited to the FDA first advisory committee meeting regarding dexfenfluramine approval. The committee vote was jimmied as the questions were changed after some attendees left the meeting. Another meeting was held and the pulmonary experts were not invited. Offers to conduct pulmonary studies in conjunction with industry were rejected. Top industry representative lied under oath about reported heart valve incident reporting at the second meeting. Reports of valvular heart disease from the field were mislabled, ignored and unreported to the FDA. Politicians like Alexander Haig, Newt Gingrich, and Congressman McDermott were lobbied to interfere in Committee and FDA oversight.

Business as usual in Washington D.C.